Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gaboxadol Add-on to Escitalopram in Major Depressive Disorder
NCT00807248Phase 2Completed
- Sponsor
- Lundbeck
- Start
- Nov 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of gaboxadol in major depressive disorder (MDD), sponsored by Lundbeck. Started Nov 2008; status: completed.
02
Drugs
gaboxadol
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00807248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00807248.